Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance
about
Inflammation and insulin resistanceExercise or exercise and diet for preventing type 2 diabetes mellitus10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyHypoglycemic agents and potential anti-inflammatory activityTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionType 2 diabetes and cognitive impairment: linking mechanismsCombined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.Targeting inflammation in diabetes: Newer therapeutic optionsLink between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentRegenerative therapies for diabetic microangiopathyHbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapyObesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions.The prevention of type 2 diabetes.Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)EJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.AMPK activation: a therapeutic target for type 2 diabetes?Metformin pharmacogenomics: current status and future directions.Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program.A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study.Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.Diabetes, related conditions, and dementia.Prevention of Diabetes Through the Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to PracticeEffects of a community-based weight loss intervention on adipose tissue circulating factorsRelationship of carotid intima-media thickness and duration of vegetarian diet in Chinese male vegetarians.Therapeutic approaches to target inflammation in type 2 diabetesEffect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis.Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial.Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer.Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetesMenopause and risk of diabetes in the Diabetes Prevention ProgramDiabetes mellitus and periodontal diseases.Incident hyperglycaemia among older adults with or at-risk for HIV infection.Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase- lowering effects of garlic in patients with type 2 diabetes mellitus with obesity.A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.Relationship of body size and shape to the development of diabetes in the diabetes prevention program.Influence of lifestyle factors on inflammation in men and women with type 2 diabetes: results from the National Health and Nutrition Examination Survey, 1999-2004.
P2860
Q22241893-DB0B2434-1BCD-4351-91E1-9DA58386D1AEQ24241914-3DD98E4F-43A2-46BE-A110-D2AF23081DDCQ24633604-BC59589F-5E85-451B-B805-DAEFB45034D0Q26750414-F91D621A-29B8-433A-933E-C339D5040DE2Q26822066-F5AEE4A4-4B1A-4F92-9A35-C1D702732C6AQ26822993-263DFE67-E655-4B82-9D0D-ED167529131AQ26851536-C014A1F5-5214-4833-B688-671ED367DDC8Q26852726-6FF2D1BB-CB8E-4022-9923-48D75449B389Q26860246-B7485DB9-7244-467D-B2E5-2AFE09862C0EQ27027852-0B71592A-FECC-44D5-86D7-A5F61BB8C9F3Q27335063-F214865F-4CA8-4676-B905-C8A83BF331FBQ28068120-5C6610EB-2C41-40E0-9CDE-4B1E564A83F7Q30415102-D28CFAB6-F94F-40D9-9071-0D11B19F481BQ30484253-6C4F8DA2-3FD3-40A0-B086-FD064935CA78Q30597265-3B3805DB-6162-4BC6-9AAD-1B95DD53F119Q33556796-826619D3-F980-47E7-B090-BD4C6D7C5BF5Q33660008-AA0F5B75-4C57-4E1A-93BE-E828BE541AF7Q33763380-528DDC52-4F91-45AF-84DB-2401E5B97720Q33824564-3C318638-BB19-49A6-8122-0B3AB6DBEE1BQ33959731-6FBED939-CFB2-4DED-9017-91399C26E865Q33960260-5BF4D4DB-520F-47F1-A09C-B72ECD6E6E42Q34219412-76E7F593-6873-4782-B141-A8ABE58B95DFQ34237273-884F0ABA-DF72-4584-8118-D94E2B3524A3Q34294192-FED3F1BB-2D43-4993-86AD-697DD0816962Q34361375-2F90B337-29D4-4127-9931-19313242D7C2Q34459235-90E1F793-D38E-4223-BA6A-0D8FE08B020DQ34623147-64A5DC00-158E-40E1-9D5C-BA41F08EC0CBQ34632427-ECF63AEA-2610-49A0-9B7F-1DCF47C09FA0Q35581498-2C47FFC3-C25E-4F32-898F-8A0D5C02E74CQ35755979-F498FCC2-EB0B-4C4A-B107-ED2AB57A8741Q35930163-BD607B4A-D936-4E1E-BE9C-9B56073CD5A5Q36035997-492CE2F3-3905-494C-8885-2A1BC2DD100AQ36277804-AEACA35C-7673-4C5A-A78E-BD5534E8C9DAQ36407356-967A909C-0690-4A00-A0ED-964C9F8D9032Q36553573-13838D64-7614-412A-994B-596BDDEA57CAQ36554781-139CF609-DF2A-42C5-AF32-6FD9A63E8532Q36560059-EC0220C7-ED6E-4E20-AB40-E964DD53C815Q36596873-47C2AE0F-C902-4F49-8707-E9CED9CB38E6Q36640356-85E7A89A-CC07-4D9C-A02F-DC8E40B4DEA3Q36664090-252B0080-60BF-47FB-BC50-E1016BEA521E
P2860
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@ast
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@en
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@nl
type
label
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@ast
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@en
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@nl
prefLabel
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@ast
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@en
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@nl
P2093
P2860
P50
P1433
P1476
Intensive lifestyle interventi ...... ith impaired glucose tolerance
@en
P2093
Edward Horton
Jill Crandall
Kieren Mather
Marinella Temprosa
Robert Ratner
Ronald Goldberg
Santica Marcovina
Sarah Fowler
Steven Haffner
P2860
P304
P356
10.2337/DIABETES.54.5.1566
P407
P577
2005-05-01T00:00:00Z